This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AGU, APH, ANN, ADM


Ariad Pharmaceuticals (ARIA - Get Report) is upgraded to hold at TheStreet Ratings. Agrium (AGU - Get Report) estimates and target were reduced at Goldman Sachs. Shares of AGU are now seen reaching $86. Estimates were also cut, given lower realized margins, Goldman said. Neutral rating.

Amphenol (APH - Get Report) was downgraded at Ticonderoga from Neutral to Sell. Valuation call, based on a $38 price target, Ticonderoga said.

Ann Taylor (ANN) numbers were increased at UBS. Shares are now seen reaching $33. Estimates were also increased on strong sales and margin gains at LOFT, e-commerce and outlets, UBS said. Buy rating.

Archer-Daniels (ADM - Get Report) was initiated with a Neutral rating at Ticonderoga. The company is trading at book value, but lacks near-term catalysts, Ticonderoga said.

Brocade's (BRCD - Get Report) target was raised at ThinkEquity. Shares are now seen reaching $6, according to ThinkEquity. Company is carrying a lot of momentum into 2012, ThinkEquity said. Buy rating.

CBOE Holdings (CBOE - Get Report) estimates were raised at Oppenheimer through 2012. Exceptional market volatility drove an exceptional quarter, Oppenheimer said. Maintain $29 price target and Outperform rating.

Church & Dwight (CHD - Get Report) numbers were increased at Jefferies. Estimates were raised through 2012. Company is positioned well for a slow-growth environment, Jefferies said. Hold rating and new $43 price target.

Church & Dwight estimates were lowered through 2012 at UBS. Some noise, but a generally in-line quarter, UBS said. Maintain $44 price target and Neutral rating.

Clean Harbors (CLH - Get Report) numbers were increased at Goldman Sachs. Estimates were raised through 2013. Company is seeing higher sales, Goldman said. Neutral rating and new $57 price target.

CME (CME - Get Report) target was boosted at Jefferies. Shares are now seen reaching $315. Core business trends are picking up, Jefferies said. Buy rating.

Comcast (CMCSA - Get Report) estimates, target were cut at Morgan Stanley. Shares are now seen reaching $27. Estimates were also reduced, given lower expected results at NBC Universal, Morgan Stanley said. Equal-weight rating.

Consolidated Edison (ED - Get Report) numbers were boosted at Goldman Sachs. Shares are now seen reaching $52. Estimates were also increased, given a better outlook for the company's nonregulated assets, Goldman said. Sell rating.

Con-Way (CNW) estimates were lowered at Sterne Agee through 2012. Pension and 401(k) headwinds, Sterne Agee said. Maintain Buy rating and $48 price target.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
DTV $0.00 0.00%
ANN $44.89 0.00%
SFD $0.00 0.00%
CNW $0.00 0.00%
ADM $40.26 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs